Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tanner

Showing results (771-780 of 855) with videos related to

Pageof 86
Sort By:
Archives of Neurology|October 14, 2009
Urate as a predictor of the rate of clinical decline in Parkinson diseaseAlberto Ascherio, Peter A LeWitt, Kui Xu, et al.
Parkinsonism & Related Disorders|October 15, 2013
Dietary fat intake, pesticide use, and Parkinson's diseaseFreya Kamel, Samuel M Goldman, David M Umbach, et al.
Journal of Clinical Microbiology|March 27, 2009
Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testingR M Lloyd, D A Burns, J T Huong, et al.
Journal of the Neurological Sciences|March 22, 2017
Caffeine, creatine, GRIN2A and Parkinson's disease progressionDavid K Simon, Cai Wu, Barbara C Tilley, et al.
Annals of Neurology|May 7, 2026
How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein DiseaseTanya Simuni, Christopher S Coffey, Catherine M Kopil, et al.
JAMA Network Open|August 11, 2023
American Football Play and Parkinson Disease Among MenHannah J Bruce, Yorghos Tripodis, Michael McClean, et al.
Plos One|April 4, 2012
A high-density genome-wide association screen of sporadic ALS in US veteransLydia Coulter Kwee, Yutao Liu, Carol Haynes, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trialEllen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Blood|May 17, 2003
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B StudyClaudia D Baldus, Stephan M Tanner, Amy S Ruppert, et al.
Pageof 86

Showing results (771-780 of 855) with videos related to

Sort By:
Pageof 86
Archives of Neurology|October 14, 2009
Urate as a predictor of the rate of clinical decline in Parkinson diseaseAlberto Ascherio, Peter A LeWitt, Kui Xu, et al.
Parkinsonism & Related Disorders|October 15, 2013
Dietary fat intake, pesticide use, and Parkinson's diseaseFreya Kamel, Samuel M Goldman, David M Umbach, et al.
Journal of Clinical Microbiology|March 27, 2009
Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testingR M Lloyd, D A Burns, J T Huong, et al.
Journal of the Neurological Sciences|March 22, 2017
Caffeine, creatine, GRIN2A and Parkinson's disease progressionDavid K Simon, Cai Wu, Barbara C Tilley, et al.
Annals of Neurology|May 7, 2026
How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein DiseaseTanya Simuni, Christopher S Coffey, Catherine M Kopil, et al.
JAMA Network Open|August 11, 2023
American Football Play and Parkinson Disease Among MenHannah J Bruce, Yorghos Tripodis, Michael McClean, et al.
Plos One|April 4, 2012
A high-density genome-wide association screen of sporadic ALS in US veteransLydia Coulter Kwee, Yutao Liu, Carol Haynes, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trialEllen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Blood|May 17, 2003
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B StudyClaudia D Baldus, Stephan M Tanner, Amy S Ruppert, et al.
Pageof 86